Latest news with #Jr
South Wales Argus
6 days ago
- Sport
- South Wales Argus
New challenge launched ahead of Lionesses' semi-final against Italy
Nine of the 14 penalties in Zurich were missed - with England edging through after the shootout went to sudden death. England looked to be going out in regular time until Lucy Bronze's header kickstarted the comeback in the 79th minute to make it 2-1 and then Michelle Agyemang pulled them level two minutes later - both goals assisted by Chloe Kelly. And ss the Lionesses gear up for their semi-final match against Italy next Tuesday, fast-food chain Wendy's will be rolling out its '4-Corner Challenge' to get the nation behind England's challenge to retain their trophy. Through the challenge, customers have a chance to win Wendy's menu items as prizes by scoring up to four goals in a penalty-style game featuring a custom Wendy's goal. Prizes include free Halloumi Fries, Mini Doughnuts, and even Wendy's much-loved Biggie Bag®: the Jr. Cheeseburger made with fresh beef**, 4-piece chicken nuggets, small fries, and a small drink. (Image: Wendy's) Michael Clarke, Managing Director, Europe for The Wendy's Company, commented: "Women's football is soaring in both popularity and talent, and as the Queen of QSR, Wendy's is proud to be part of its incredible rise. 'Just like our square hamburgers, we believe in doing the right thing – no shortcuts, no cutting corners. That's why we're backing our passion with action through the Wendy's 4-Corner Challenge. We can't wait to cheer alongside fans for every thrilling moment!' Against Sweden, it was defender Lucy Bronze, England's seventh penalty taker, that slammed her spot-kick into the roof of the net before Smilla Holmberg put her effort over the bar at the end of a chaotic shootout. Sweden only scored two of their seven penalties, with England goalkeeper Hannah Hampton saving two of them, while her Swedish counterpart Jennifer Falk kept out four spot-kicks and missed a chance to win it when she put her shot over the bar. And now Wendy's customers will need to channel their inner Lucy Bronze if they too are going to get their hands on prizes next week. At Wendy's® – home of the iconic square hamburger – corners aren't just part of their game; they are part of their DNA. That's why, with the nation buzzing with football fever, Wendy's is making the ultimate wager that could see fans across the UK feasting on its fresh, famous food for free. Fancy yourself as the next Alessia Russo? The 4-Corner Challenge will roll out across the following Wendy's restaurants so grab your trainers and give it a go: Watford – 20th July 2025, 10:30-19:00 Lakeside Shopping Centre – 23rd July, 09:00-19:00 Leeds – 26th July, 09:30-19:00 Keep an eye on Wendy's UK Instagram and Facebook for further announcements throughout the Euros tournament!
USA Today
16-07-2025
- Politics
- USA Today
Who was John Lewis? The civil rights icon inspires 'Good Trouble' protests
Tens of thousands of people are expected to turn out across the country this week to protest President Donald Trump's administration and to honor the legacy of one of the nation's most enduring figureheads in the fight for social justice, John Lewis. The protests, "Good Trouble Lives On," are expected to take place in dozens of cities and towns on July 17, five years to the day since Lewis' death in 2020. The late congressman, who led some of the most seminal demonstrations during the Civil Rights movement, popularized the phrase "good trouble," referring to the kind of nonviolent action and civil disobedience he became known for early in his career. The late 17-term congressman was often called the 'moral compass'' of the U.S. House of Representatives, but he made a name for himself long before he became a lawmaker, as one of the youngest leaders in the Civil Rights movement of the 1950s and 1960s. Lewis' biography as a civil rights activist and lawmaker is a long one, involving some of the most significant U.S. political events and figures of the mid-20th century. Here's a brief overview of his past, as planned protests invoke his legacy on July 17. 'Good Trouble' protest locations: See where demonstrations are planned Where was John Lewis born? Lewis is the son of Alabama sharecroppers, born in Troy, Pike County, Alabama on February 21, 1940. Lewis began preaching in local churches when he was 15 years old, according to a biography from Stanford's Martin Luther King, Jr. Research and Education Institute. He then enrolled in the American Baptist Theological Seminary in Nashville after high school. Lewis first met Martin Luther King Jr. in 1958, when he traveled to Montgomery, Alabama, to seek King's help in suing to transfer to Troy State University, an all-white institution closer to his home, according to the institute. Though he ended up not pursuing the litigation, the experience connected Lewis with King and other Black Civil Rights leaders and gave him his nickname, 'the boy from Troy." Inspired to 'get in good trouble again:' Black lawmakers salute the legacy of John Lewis What did John Lewis do during the Civil Rights movement? As a leader in the civil rights movement of the 1960s, Lewis challenged Jim Crow segregation across the South, participating in and leading many nonviolent protests. "Lewis became heavily involved in the Nashville movement and participated in a series of student sit-ins in early 1960 that aimed to integrate movie theaters, restaurants, and other businesses," the MLK Research and Education Institute said, "In April 1960, he helped form SNCC (the Student Nonviolent Coordinating Committee) and later participated in the Freedom Rides of 1961." During this time, he rose to prominence within the movement, as chronicled by the National Archives and the John F. Kennedy Presidential Library Archives. He was among a group who met with Kennedy in 1963 ahead of the historic March on Washington, and addressed the many thousands who descended upon the National Mall that day before King took the stage to deliver his 'I Have a Dream Speech.' John Lewis' involvement in 'Bloody Sunday' in Selma, Alabama Among all demonstrations and actions, he is perhaps most known for his involvement in what would be called "Bloody Sunday." Lewis helped lead hundreds of peaceful protestors across the Edmund Pettus Bridge in Selma, Alabama on March 7, 1965 in support of equal voting rights for Black Americans. The protesters, including a then-25-year-old Lewis, where beaten back brutally by state troopers. Lewis suffered a fractured skull, and many others were injured by deployed gas, clubs, whips, and other weapons wielded by police. The brutal attack galvanized public support for the movement and is seen as a pivotal precursor to the passing of the Voting Rights Act of 1965. Until his health failed, Lewis had led an annual bipartisan congressional pilgrimage to Selma to mark that anniversary. He stopped by the pilgrimage months before his death. What was John Lewis' political legacy as a Democratic congressman from Georgia? In 1987, Lewis was elected to represent Georgia's 5th District in the U.S. House of Representatives, often taking the lead on debates and legislation connected to civil rights and social justice, becoming known as the "conscience of the Congress," according to the National Archives. Former Speaker of the House Nancy Pelosi said she learned a lot from Lewis during their 30 years serving together in Congress. Pelosi said ''he taught us through words and action what true moral leadership looked like,' while members of the Congressional Black Caucus told USA TODAY that Lewis inspired them to continue the push for civil rights. Lewis was an ally to Presidents Bill Clinton and Barack Obama and was an outspoken critic of the invasion and subsequent years-long war in Iraq. He also became a leading voice against gun violence and advocated for gun control legislation prominently following the shooting of former Rep. Gabby Giffords. "We have been too quiet for too long,'' Lewis said during a 2016 sit-in in the House chambers over gun control legislation. 'There comes a time when you have to say something, when you have to make a little noise, when you have to move your feet. This is the time.' Contributing: Deborah Barfield Berry and Susan Page, USA TODAY. Kathryn Palmer is a national trending news reporter for USA TODAY. You can reach her at kapalmer@ and on X @KathrynPlmr.
Forbes
09-07-2025
- Business
- Forbes
The Quiet Renewable Race: Private Equity's Bid For Prime Energy Land
WHITEWATER, CALIFORNIA - DECEMBER 05 : Wind turbines produce energy at Whitewater Energy's Wind ... More Turbine Farm, December 5, 1997 in Whitewater, California near Palm Springs. (Photo by Getty Images/Bob Riha, Jr.) Private equity is quietly becoming one of the most potent forces in the future of clean energy—not just by financing solar panels and wind turbines but also by owning the land beneath them. These strategic moves could reshape how fast renewable power is deployed, who controls it, and whether communities benefit equitably. TPG Global's potential $2.34 billion acquisition of Altus Power marks just one of many high-profile deals this year. Stoa SA and EDF Brasil Holding are also vying for Geração Céu Azul SA, a Brazilian hydroelectric operator. Meanwhile, Brookfield Asset Management recently bought French renewables company Neoen for $7 billion, and Energy Capital Partners acquired Atlantica Sustainable Infrastructure for $2.6 billion. KKR has bid $3 billion for Germany's Encavis. 'Wind and solar generation require at least 10 times as much land per unit of power produced than coal- or natural gas-fired power plants, including land disturbed to produce and transport the fossil fuels,' writes Samantha Gross, director of energy and climate for the Brookings Institution. 'Additionally, wind and solar generation are located where the resource availability is best instead of where is most convenient for people and infrastructure, since their 'fuel' can't be transported like fossil fuels.' S&P Global said private equity and venture capital transactions in the global renewable energy sector hit nearly $15 billion in 2023, or 104 deals. Given the influx of artificial intelligence data centers, these ventures are critical as the global economy's appetite for electricity will spike. Specifically, wind and solar are 17% of the U.S. energy mix and about 13% of the worldwide portfolio. China is the biggest user of renewable energy, accounting for 30% of its electricity pie. As global electricity demand surges—driven by AI data centers, electric vehicles, and industrial electrification—private equity firms are racing to secure the most valuable real estate for renewables. They're not just investing in clean power but also cornering the market on where it gets built. That raises red flags. Consider that land with consistently strong winds, high solar insolation, and good grid access is hard to find. If private equity firms dominate these properties, it could drive up the prices of less desirable lands. That cost may ultimately fall on consumers through higher electricity prices or delayed clean energy rollouts. That's an unhealthy development, particularly as nearly every nation races to decarbonize. 'Private equity is a growing force in renewable energy—specifically in wind and solar. It's a natural fit for growth-oriented, long-term investors like private equity,' said the American Investment Council, which promotes private equity. 'In years past, many clean energy producers relied on government subsidies for capital,' it added. 'With private equity sponsors, wind and solar companies get much more than that—a patient source of capital, knowledgeable sponsors who can help companies navigate regulatory hurdles, and growth-oriented investors who can push clean energy producers to new heights.' Investors Pony Up Dominion Energy's first two turbines — part of a planned wind farm are about 30 miles off the ... More Virginia Beach coast. The Coast Guard already is planning how to conduct search and rescue operations around the massive structures. A turbine is seen Sept. 27, 2021. (Stephen M. Katz/The Virginian-Pilot/Tribune News Service via Getty Images) Over the last decade, the council has pegged domestic wind and solar investments at more than $130 billion. Since 2012, private equity sponsors have financed almost 3,000 energy enterprises across the spectrum, worth $617 billion. Private equity firms also back utility companies, including Puget Sound Energy, Hawaii Gas, El Paso Electric, AES Indiana, and People's Gas, which serves Pennsylvania, West Virginia, and Kentucky--states heavily involved in the old economy. Don't get me wrong: private equity is firstly interested in new tech--making better and cheaper stuff. But they're also really into acquiring land now. The 'losers' build projects far from transmission lines, which means expensive and time-consuming grid upgrades, especially in areas that don't want them. That puts the private funds in an enviable position, leaving local communities and other energy producers disadvantaged. 'The electricity sector is transforming into a major growth area for both the U.S. and global economy, with forecasts projecting electricity demand will skyrocket' — to perhaps double over 15 years,' said Doug Kimmelman, founder of Energy Capital, in a statement. The 21st-century economy, with AI data centers and electric vehicles, drives the demand. The smart money thinks several steps ahead. The influx of capital is a net positive, fueling innovation and scaling operations. Investors, though, bring more than money. They accelerate deployment. The International Renewable Energy Agency says the mission is to triple the use of renewables, adding at least 1 million megawatts of new capacity annually until 2030. We must reduce CO2 levels by 43% by 2030 and 60% by 2035. There is a lurking concern: without careful oversight, it could also require a new kind of gatekeeping. Indeed, this ambitious expansion must be balanced with concerns about land acquisition. Policymakers can address both problems. Regulatory approaches can speak to fears over land concentration, while jurisdictions can prioritize community-owned projects through preferential permitting or financing. No one wants to slow down the deployment of renewable energy. However, communities are increasingly wary of bearing environmental and social costs without proper safeguards, reminiscent of sentiments from coal-dependent regions. Given this history, it's imperative to approach renewable energy development thoughtfully and inclusively.
Yahoo
03-07-2025
- Health
- Yahoo
MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention ('CDC') adopted new recommendations for the use of RSV vaccines in the upcoming respiratory virus season. The revised recommendations lower the recommended age for RSV vaccination. Now, adults aged 50-59 who are at higher risk of severe illness from the disease are advised to receive a single dose of the vaccine. The previous CDC guidance recommended RSV vaccines for people aged 75 and older, as well as those aged between 60-74 who were at high risk of the disease. Per the CDC's website, this recommendation was officially adopted last week by the current HHS secretary, Robert F. Kennedy, Jr. Although the CDC director typically accepts or rejects such recommendations, the position is currently vacant, so Kennedy fulfilled that role. President Trump has backed Susan Monarez as his nominee for the post, but her appointment is still pending confirmation by the U.S. Senate. The broader recommendations come as a surprise because the members of the CDC's advisory committee — who initially made the recommendation earlier this year — were all removed by RFK Jr. last month. Year to date, the stock has lost 27% compared with the industry's 2% decline. Image Source: Zacks Investment Research The expanded CDC recommendations widen Moderna's addressable market for its RSV vaccine, mResvia. By lowering the recommended age group, the guidance opens up a new segment of eligible patients who were previously excluded. Moderna is one of a handful of companies marketing an RSV vaccine. Though mResvia was initially approved last year for use in people aged 60 and older, the FDA expanded its label last month to include high-risk individuals aged between 18-59. Despite commercially launching the vaccine last year, mResvia sales were modest as it was approved and recommended later in the contracting season. By that point, many people had already completed their vaccinations with either GSK's GSK Arexvy or Pfizer's PFE Abrysvo. RSV vaccines gained traction in 2023 with the initial approvals of Arexvy and Abrysvo — the first FDA-approved RSV vaccines. At the time, the CDC issued blanket approvals for use among individuals aged 60 and older. However, the CDC later narrowed that guidance, which trimmed the target market last year. That, combined with the earlier availability of GSK and Pfizer's offerings, gave both companies a dominant position over Moderna. Both GSK and Pfizer vaccines are already approved for use in individuals aged 60 and older. While GSK's Arexvy is approved for use in high-risk individuals aged 50-59, PFE's Abrysvo is approved for use in high-risk people aged 18-59. The Pfizer vaccine is also approved for use in infants through maternal immunization. Moderna, Inc. price | Moderna, Inc. Quote Moderna currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report Pfizer Inc. (PFE) : Free Stock Analysis Report Moderna, Inc. (MRNA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
27-06-2025
- Health
- Yahoo
Bavarian Nordic begins mpox vaccine trial in pregnant women and infants
Bavarian Nordic has initiated two Phase III clinical trials of its mpox vaccine, Jynneos, in pregnant and breastfeeding women, as well as infants aged under two years. The first infants have been dosed in one Phase III study (NCT06844487), which aims to recruit 344 infants aged between four months and two years. In addition, the recruitment for 359 pregnant and breastfeeding women has started for an additional trial (NCT06844500). Both studies are part of the PregInPoxVac project. The PregInPoxVac project is led by the University of Antwerp and the University of Kinshasa and is supported by partners in Kenya (ACE Research) and Italy (Penta Foundation). It is funded by the European Union Global Health EDCTP3, the Coalition for Epidemic Preparedness Innovations (CEPI), and Bavarian Nordic. The studies will evaluate the safety and immunogenicity of MVA-BN in those living in the Democratic Republic of Congo (DRC), the epicentre of the ongoing mpox outbreak, where infants and pregnant women remain highly vulnerable to mpox. Bavarian Nordic CEO Paul Chaplin said: 'Through partnerships, we have made significant advances already by expanding access to our mpox vaccine for children and adolescents. "These new studies will fill the gap by providing important data about the use of MVA-BN in infants and pregnant women, and we applaud the study partners as well as the funding partners, EDCTP3 and CEPI for supporting this important work which could help support a label expansion for MVA-BN to include the most vulnerable populations.' Bavarian Nordic is also sponsoring a trial (NCT06549530) of MVA-BN in children aged 2-11 years, with topline data anticipated in Q3 2025. Jynneos is the only non-replicating mpox vaccine approved in the US, EU, Switzerland, Singapore and Mexico. It is also approved in the UK, where it is marketed as Imvanex. The vaccine was originally developed for smallpox, but studies have proven its efficacy in mpox. Last year, after the outbreak was confirmed, Bavarian Nordic set up studies in the epicentre and also promised 2.5 million doses of the jab to Africa via an agreement with UNICEF, which included a 500,000-dose commitment by the Global Alliance for Vaccines and Immunization (GAVI). Yesterday, US Health Secretary Robert F Kennedy, Jr (RFK) announced that the US would no longer financially support GAVI, according to Politico. This comes months after the country also stated it would be dropping certain funding to USAID, which also assists with vaccine distribution and research in third-world countries. Earlier this year, Bavarian Nordic shares rose 7% on its Q1 financial announcement, with strong revenue from vaccine sales. On top of this, the company also gained $160m earlier this month after it sold a priority review voucher; however, the buyer has not been disclosed. "Bavarian Nordic begins mpox vaccine trial in pregnant women and infants" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
